Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,685 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gorham-Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage.
Morimoto N, Ogiwara H, Miyazaki O, Kitamuara M, Nishina S, Nakazawa A, Maekawa T, Morota N. Morimoto N, et al. Among authors: maekawa t. Int J Pediatr Otorhinolaryngol. 2013 Sep;77(9):1596-600. doi: 10.1016/j.ijporl.2013.06.004. Epub 2013 Jul 2. Int J Pediatr Otorhinolaryngol. 2013. PMID: 23827687
Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M, Asada R, Saito AM, Hashimoto H, Fujimura T, Kuroda T, Ueno S, Watanabe S, Nosaka S, Miyasaka M, Umezawa A, Matsuoka K, Maekawa T, Yamada Y, Fujino A, Hirakawa S, Furukawa T, Tajiri T, Kinoshita Y, Souzaki R, Fukao T. Ozeki M, et al. Among authors: maekawa t. Regen Ther. 2019 Jan 14;10:84-91. doi: 10.1016/j.reth.2018.12.001. eCollection 2019 Jun. Regen Ther. 2019. PMID: 30705924 Free PMC article.
Immunologic Effects of Sirolimus in Patients With Vascular Anomalies.
Nozawa A, Ozeki M, Yasue S, Endo S, Kawamoto N, Ohnishi H, Fumino S, Furukawa T, Tajiri T, Maekawa T, Fujino A, Souzaki R, Fukao T. Nozawa A, et al. Among authors: maekawa t. J Pediatr Hematol Oncol. 2020 Jul;42(5):e355-e360. doi: 10.1097/MPH.0000000000001650. J Pediatr Hematol Oncol. 2020. PMID: 31743321
Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.
Ozeki M, Endo S, Yasue S, Nozawa A, Asada R, Saito AM, Hashimoto H, Fujimura T, Yamada Y, Kuroda T, Ueno S, Watanabe S, Nosaka S, Miyasaka M, Umezawa A, Matsuoka K, Maekawa T, Hirakawa S, Furukawa T, Fumino S, Tajiri T, Takemoto J, Souzaki R, Kinoshita Y, Fujino A. Ozeki M, et al. Among authors: maekawa t. Front Med (Lausanne). 2024 Feb 8;11:1335469. doi: 10.3389/fmed.2024.1335469. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38390569 Free PMC article.
Population pharmacokinetic analysis of sirolimus in Japanese pediatric and adult subjects receiving tablet or granule formulations.
Miyazaki T, Hayashi D, Nozawa A, Yasue S, Endo S, Ohnishi H, Asada R, Kato M, Fujino A, Kuroda T, Maekawa T, Fumino S, Kawakubo N, Tajiri T, Shimizu K, Sanada C, Hamada I, Ishikawa Y, Hasegawa M, Patel K, Xie Y, Ozeki M. Miyazaki T, et al. Among authors: maekawa t. Drug Metab Pharmacokinet. 2024 Dec;59:101024. doi: 10.1016/j.dmpk.2024.101024. Epub 2024 May 31. Drug Metab Pharmacokinet. 2024. PMID: 39427366
1,685 results